The Department of Atomic Energy is inviting tenders for the procurement of Cytotoxic Drug Dispensing Cabinets under the reference number GEM/2025/B/6118614. This tender encompasses the acquisition of a total of six units of specialized drug dispensing cabinets designed for handling hazardous pharmaceutical compounds safely and efficiently.

Scope of Work and Objectives

The primary objective of this tender is to acquire Cytotoxic Drug Dispensing Cabinets that meet stringent safety and operational requirements essential for oncology and pharmaceutical practices. These cabinets must be suitable for the safe handling, storage, and compounding of cytotoxic drugs, ensuring compliance with health regulations and safety guidelines.

Eligibility Criteria

Interested bidders must fulfill certain eligibility requirements to participate in this tender. Eligible entities include registered manufacturers, authorized dealers, or suppliers who can demonstrate their capacity to provide the required units. Additionally, bidders should provide evidence of satisfactory past performance in supplying similar equipment.

Technical Requirements

Bidders are expected to ensure that the Cytotoxic Drug Dispensing Cabinets adhere to specific technical specifications. Requirements may include:

• Compliance with international safety standards for handling cytotoxic agents.
• Features that support effective ventilation, containment, and protection mechanisms.
• Compatibility with electronic systems for inventory management and monitoring.

Financial Requirements

Bidders must submit financial documents that emphasize their ability to fulfill the contract effectively. This includes:

• Proof of financial stability.
• Information on pricing models and payment terms.
• Details of warranty and after-sales support provisions.

Document Submission Details

For participation in this tender, all required documents must be submitted electronically through the designated platform. Each submission must include:

• Completed tender forms.
• Technical and financial proposals.
• Any additional certificates or evidence supporting the eligibility criteria.

Special Provisions

This tender may provide benefits for Micro, Small, and Medium Enterprises (MSEs) and startups, fostering inclusivity and diversity in the supply chain. Eligible participants are encouraged to highlight their status during the application to take advantage of potential preferential considerations.

Evaluation Process

The evaluation of submitted bids will be conducted based on both technical and financial criteria. The assessment will primarily focus on:

• Adherence to provided technical specifications.
• Pricing structures and overall value proposition.
• Supplier reliability and past performance record.

Delivery Locations

The delivery of the Cytotoxic Drug Dispensing Cabinets must be scheduled at the designated facilities indicated in the tender documentation. Successful bidders will receive specific instructions and timelines for delivery after the evaluation process.

Contact Information

For any inquiries related to this tender, potential bidders can refer to the official communication channels provided by the Department of Atomic Energy. It is advisable to ensure all questions are directed through the established contact points to receive accurate information.

In summary, this tender for Cytotoxic Drug Dispensing Cabinets represents an important initiative by the Department of Atomic Energy to enhance healthcare safety and operational efficiency in managing cytotoxic medications. All interested and eligible bidders are encouraged to participate, ensuring they meet the outlined criteria and requirements.